The mission behind Helix

The starting point is not one more app among 350,000. It's the unified score, sleep, movement, stack, nutrition, biomarkers, built for the hardest users to convince on the market: biohackers, athletes, neurodivergent people, chronic patients, founders. The ones who already track everything and believe nothing without a source.

And it's free. Not free for a launch window: free because charging this audience would mean sacrificing the one thing everything else depends on. Earning their trust produces two assets no budget can buy: a cohort of dense, longitudinal, consented data, and a reputation for rigor. It's that trust, not capital, that unlocks Phase 2.

If the user doesn't pay, someone has to: the products do. The supplements market exceeds $200 billion, yet the vast majority of health claims has never been validated by the EFSA. Nobody really knows what they're swallowing, and nobody plays the trusted third party.

Creapure didn't reinvent creatine: it guaranteed its purity, and it took the market. Helix applies that logic to the supplements and sensors it recommends: batch analysis, origin, purity, verifiable behind a QR code and backed by real Phase 1 data. We don't sell a promise, we sell certainty. This is the first revenue, and it's what pays for free.

Serving companies with doctors doesn't scale: the more employees, the more doctors, and costs climb as fast as headcount. You don't put a horde of doctors behind a hundred thousand people. So we flip the order: before selling the service, we build the tool. A handful of doctors doesn't execute the recommendations, it teaches the model: on the volunteered, anonymized data from Phase 1, they issue their own, correct the model's, and every correction becomes training data. The doctor stops being a cost that grows with every client: they become an investment that improves the product for everyone.

Every health AI is trained on snapshots, a blood panel here, a questionnaire there: it has never watched a life unfold. The Phase 1 dataset, dense, longitudinal and volunteered, is precisely what can neither be bought nor caught up on. And no need for a giant model that knows everything: a specialized model, trained on medicine and nothing else, backed by a validated knowledge base, lighter, cheaper, hosted on European infrastructure. Sovereign end to end. Its job is to assist doctors, never to replace them.

Disengagement and poor health at work cost about 9% of global GDP (Gallup): employers already pay for cosmetic wellbeing, they'll pay for the real thing. Employees get the app, medical follow-up and real support (supplements, training, nutrition, and so on): the Phase 3 model handles the routine, doctors keep the complex cases, and the cost no longer climbs with headcount. The employer never sees an individual: they get their teams' health baseline, its trend, and nothing below a minimum headcount. Medical confidentiality is not negotiable, and a team average is not medical data.

A dashboard that surfaces turnover, productivity and the health level of the teams. The benefits of a bonus evaporate within weeks, while those of a healthier team stay. And a team that ages badly loses its creativity as the company erodes. We start with the ones who already look after their health: sports clubs and desk work. The channel has existed since Phase 1, those users are founders, managers, freelancers, and they recommend what they use.

Physical jobs stack everything: accident risk, occupational illness, shift work, and wages that leave little room for prevention. Public healthcare reimburses less every year, private cover costs more: for many people, the workplace becomes the last place prevention can still reach them.

Same core, adapted to the field: medical follow-up, supplements, healthy canteen food designed around real individual needs, sessions and local partnerships organized on site. For fewer accidents, fewer sick days, less wear from the job and better health. Here the plan makes rising profitability converge entirely with the common good (health, happiness).

According to the WHO, chronic diseases account for three out of four deaths worldwide, and the vast majority of cardiovascular diseases, the leading cause of death, are preventable. The problem lies not in medicine itself, but in the scope of the perspective: an annual check-up captures a snapshot, whereas Helix captures the full movie. The Phase 3 model provides doctors with a medical history that a standard consultation cannot reconstruct, along with the ability to detect subtle early warning signs across assessments spanning years. An early signal triggers early action: fewer late diagnoses and fewer avoidable hospital costs. Helix does not replace doctors; it gives them back their time.

The most advanced preventive health in the world doesn't happen in a hospital: it happens 400 km up, where NASA monitors every astronaut's vitals continuously, microgravity eating about 1% of bone per month. Before orbit, there is closer ground: the bottom of a mine, a polar base, a submarine. The operators of those environments will never be able to build in-house what Helix will have: a predictive system validated across thousands of ordinary lives. Same core. Maximum stakes.

The last phase is the only one that earns nothing : and that's the point. Data stays the property of the people who generated it : never sold, never rented.